Welcome to the Exeter Clinical Laboratory International website
NHS logo

CONGENITAL GENERALISED LIPODYSTROPHY (CGL)

Clinical Genetics Genomics


AGPAT2, BSCL2, CAV1, CAVIN1, LIPE, LMNA, PLIN1, POLD1, PPARG and ZMPSTE24 GENE ANALYSIS

Congenital generalised lipodystrophy (CGL) is an autosomal recessive disorder characterised by marked paucity of adipose tissue at birth or in infancy, extreme insulin resistance, acanthosis nigricans, hypertriglyceridemia, hepatic steatosis and early onset of diabetes. Additional characteristics include accelerated growth during childhood, increased basal metabolic rate, voracious appetite, acromegaloid appearance (enlarged mandible, hands and feet), hepatosplenomegaly, umbilical hernia and in women, clitoromegaly and hirsutism.

The laboratory participates in the European Molecular Genetics Quality Network (EMQN) sequencing scheme. 

Download the lipodystrophy and severe insulin resistance patient information sheets from the National Severe Insulin Resistance Service, Addenbrooke’s Hospital, Cambridge:

http://www.cuh.org.uk/sites/default/files/publications/PIN3418_lipodystrophy_v1.pdf http://www.cuh.org.uk/sites/default/files/publications/PIN3419_severe_insulin_resistance_v1.pdf

NHSE test directory code: R158 Lipodystrophy – childhood onset. Testing criteria can be found here.

University of Exeter logo
A UKAS Accredited Medical Laboratory

8092

RD&E logo